Onward Medical Revives Hope for SCI

This podcast features Matt Henriksson from Bloomberg Intelligence interviewing Dave Marver, CEO of Onward Medical, about the company's progress in developing therapies for spinal cord injuries. They discuss Onward's three technology platforms: ARC-EX, ARC-IM, and ARC-BCI, focusing on the recent de novo approval and commercialization of ARC-EX, its potential for home use, and the upcoming CE mark application. The conversation also covers the Empower BP study for ARC-IM, designed to address blood pressure instability, and the ARC-BCI, a brain-computer interface for restoring movement. They touch on clinical trials, potential new indications, and the ethical considerations surrounding BCI technology, as well as Onward's financial strategies and partnerships.